Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

EQS-News: Evotec presents sustainability strategy: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
EQS-News: Evotec presents sustainability strategy
EQS-News: Evotec presents sustainability strategy
EQS-News: Evotec receives grant from Open Philanthropy for discovery of RNA-targeting Henipavirus therapeutics: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
EQS-News: Evotec receives grant from Open Philanthropy for discovery of RNA-targeting Henipavirus therapeutics
EQS-News: Evotec receives grant from Open Philanthropy for discovery of RNA-targeting Henipavirus therapeutics
EQS-News: Bechtle AG: Bechtle Reports Higher Dividend and Expanded Supervisory Board: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24050/225px-Bechtle_AG_20xx_logo.svg.png
EQS-News: Bechtle AG: Bechtle Reports Higher Dividend and Expanded Supervisory Board
EQS-News: Bechtle AG: Bechtle Reports Higher Dividend and Expanded Supervisory Board
EQS-News: CANCOM SE: CANCOM successfully completes major step in acquisition of KBC Beteiligungs GmbH: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24051/375px-PLAN._BUILT._PERFORM..png
EQS-News: CANCOM SE: CANCOM successfully completes major step in acquisition of KBC Beteiligungs GmbH
EQS-News: CANCOM SE: CANCOM successfully completes major step in acquisition of KBC Beteiligungs GmbH
EQS-Adhoc: CANCOM SE: Conclusion of the contribution and execution agreement for the acquisition of KBC Beteiligungs GmbH; update of the forecast for the financial year 2023 in the course of consolidation: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24051/375px-PLAN._BUILT._PERFORM..png
EQS-Adhoc: CANCOM SE: Conclusion of the contribution and execution agreement for the acquisition of KBC Beteiligungs GmbH; update of the forecast for the financial year 2023 in the course of consolidation
EQS-Adhoc: CANCOM SE: Conclusion of the contribution and execution agreement for the acquisition of KBC Beteiligungs GmbH; update of the forecast for the financial year 2023 in the course of consolidation
EQS-News: MorphoSys AG Reports Outcome of Annual General Meeting 2023: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
EQS-News: MorphoSys AG Reports Outcome of Annual General Meeting 2023
EQS-News: MorphoSys AG Reports Outcome of Annual General Meeting 2023
EQS-News: Annual General Meeting of Telefónica Deutschland resolves dividend of EUR 0.18 per share for the financial year 2022: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24073/Telefonica_Logo.svg.png
EQS-News: Annual General Meeting of Telefónica Deutschland resolves dividend of EUR 0.18 per share for the financial year 2022
EQS-News: Annual General Meeting of Telefónica Deutschland resolves dividend of EUR 0.18 per share for the financial year 2022
EQS-News: freenet AG: Annual General Meeting resolves dividend of EUR 1.68 per share (previous year: EUR 1.57): http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24058/375px-Freenet_AG_Logo.svg.png
EQS-News: freenet AG: Annual General Meeting resolves dividend of EUR 1.68 per share (previous year: EUR 1.57)
EQS-News: freenet AG: Annual General Meeting resolves dividend of EUR 1.68 per share (previous year: EUR 1.57)
EQS-News: Nagarro SE posts 23.7% YoY revenue growth in Q1 2023, 22.9% in constant currency: https://upload.wikimedia.org/wikipedia/commons/0/0a/Nagarro_Horizontal_Light_400x100px_300dpi.png
EQS-News: Nagarro SE posts 23.7% YoY revenue growth in Q1 2023, 22.9% in constant currency
EQS-News: Nagarro SE posts 23.7% YoY revenue growth in Q1 2023, 22.9% in constant currency
EQS-News: VARTA AG: VARTA AG meets the challenges in a difficult market environment: https://upload.wikimedia.org/wikipedia/commons/thumb/1/13/Varta-Logo.svg/1000px-Varta-Logo.svg.png
EQS-News: VARTA AG: VARTA AG meets the challenges in a difficult market environment
EQS-News: VARTA AG: VARTA AG meets the challenges in a difficult market environment
EQS-News: Evotec publishes Annual Report 2022 and Quarterly Statement for Q1 2023: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
EQS-News: Evotec publishes Annual Report 2022 and Quarterly Statement for Q1 2023
EQS-News: Evotec publishes Annual Report 2022 and Quarterly Statement for Q1 2023
EQS-Adhoc: Nagarro SE: Adjustment in guidance for FY 2023: https://upload.wikimedia.org/wikipedia/commons/0/0a/Nagarro_Horizontal_Light_400x100px_300dpi.png
EQS-Adhoc: Nagarro SE: Adjustment in guidance for FY 2023
EQS-Adhoc: Nagarro SE: Adjustment in guidance for FY 2023
EQS-News: MorphoSys Highlights Potential of Its Mid- to Late-Stage Oncology Pipeline at 2023 ASCO and EHA Annual Meetings: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
EQS-News: MorphoSys Highlights Potential of Its Mid- to Late-Stage Oncology Pipeline at 2023 ASCO and EHA Annual Meetings
EQS-News: MorphoSys Highlights Potential of Its Mid- to Late-Stage Oncology Pipeline at 2023 ASCO and EHA Annual Meetings
EQS-News: CANCOM SE: Revenue and gross profit growth in the first quarter: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24051/375px-PLAN._BUILT._PERFORM..png
EQS-News: CANCOM SE: Revenue and gross profit growth in the first quarter
EQS-News: CANCOM SE: Revenue and gross profit growth in the first quarter
EQS-News: Bechtle Reports Strong First Quarter: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24050/225px-Bechtle_AG_20xx_logo.svg.png
EQS-News: Bechtle Reports Strong First Quarter
EQS-News: Bechtle Reports Strong First Quarter
EQS-News: Industry weakness impacts Siltronic's earnings in Q1 2023: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24068/Siltronic_Logo.svg.png
EQS-News: Industry weakness impacts Siltronic's earnings in Q1 2023
EQS-News: Industry weakness impacts Siltronic's earnings in Q1 2023
EQS-News: 1&1 with a good start to the year : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24057/Drillisch_AG_Logo.svg.png
EQS-News: 1&1 with a good start to the year
EQS-News: 1&1 with a good start to the year
EQS-News: United Internet gets off to good start in 2023: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24075/330px-UnitedInternet_logo.svg.png
EQS-News: United Internet gets off to good start in 2023
EQS-News: United Internet gets off to good start in 2023
EQS-News: Telefónica Deutschland Holding AG: Robust start to the year confirming FY23 outlook with ongoing commercial momentum driving sustained operational & financial performance: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24073/Telefonica_Logo.svg.png
EQS-News: Telefónica Deutschland Holding AG: Robust start to the year confirming FY23 outlook with ongoing commercial momentum driving sustained operational & financial performance
EQS-News: Telefónica Deutschland Holding AG: Robust start to the year confirming FY23 outlook with ongoing commercial momentum driving sustained operational & financial performance
EQS-News: Just – Evotec Biologics launches tech partnership for biosimilars development and commercial manufacturing: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
EQS-News: Just – Evotec Biologics launches tech partnership for biosimilars development and commercial manufacturing
EQS-News: Just – Evotec Biologics launches tech partnership for biosimilars development and commercial manufacturing
EQS-Adhoc: Just – Evotec Biologics enters strategic biosimilars partnership with Sandoz: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
EQS-Adhoc: Just – Evotec Biologics enters strategic biosimilars partnership with Sandoz
EQS-Adhoc: Just – Evotec Biologics enters strategic biosimilars partnership with Sandoz
EQS-News: Siltronic AG: Dr. Michael Heckmeier takes over as CEO of Siltronic AG - Annual General Meeting approves dividend of EUR 3 per share: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24068/Siltronic_Logo.svg.png
EQS-News: Siltronic AG: Dr. Michael Heckmeier takes over as CEO of Siltronic AG - Annual General Meeting approves dividend of EUR 3 per share
EQS-News: Siltronic AG: Dr. Michael Heckmeier takes over as CEO of Siltronic AG - Annual General Meeting approves dividend of EUR 3 per share
EQS-News: MorphoSys AG Reports First Quarter 2023 Financial Results: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
EQS-News: MorphoSys AG Reports First Quarter 2023 Financial Results
EQS-News: MorphoSys AG Reports First Quarter 2023 Financial Results
EQS-News: freenet AG: freenet starts the 2023 financial year with a significant increase in EBITDA: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24058/375px-Freenet_AG_Logo.svg.png
EQS-News: freenet AG: freenet starts the 2023 financial year with a significant increase in EBITDA
EQS-News: freenet AG: freenet starts the 2023 financial year with a significant increase in EBITDA
EQS-Adhoc: VARTA AG adjusts forecast for 2023: https://upload.wikimedia.org/wikipedia/commons/thumb/1/13/Varta-Logo.svg/1000px-Varta-Logo.svg.png
EQS-Adhoc: VARTA AG adjusts forecast for 2023
EQS-Adhoc: VARTA AG adjusts forecast for 2023